Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Interventional Cardiology
What is your preferred intervention for diffuse severe ISR involving two layers of stent?
Answer from: at Community Practice
Drug coated balloons
Sign In
or
Register
to read more
Answer from: at Community Practice
LASER atherectomy, high pressure PTCA to ensure stents are fully expanded preferably ICUS confirmed, followed by Brachytherapy.
Sign In
or
Register
to read more
Answer from: at Academic Institution
Atherotomy (SCOREFLEX, angiosculpt, or cutting balloon) plus DEB.
Sign In
or
Register
to read more
Answer from: at Academic Institution
I agree with drug-coated balloon.
Sign In
or
Register
to read more
30238
30269
30264
30686
Related Questions
What is your preferred duration of aggrastat therapy, and does it differ if patient presented with NSTEMI versus STEMI?
Do you prefer using echocardiographic guided or SmartAssist guided help for Impella repositioning, and why?
Do you always give 325mg aspirin if not already loaded with antiplatelets prior to the start of every LHC, even just for diagnostics in the absence of ACS?
Under what circumstances would you consider withdrawing aspirin and continuing with potent P2Y12 inhibitor monotherapy after successful PCI in patients with acute coronary syndromes, based on the findings of the NEO-MINDSET trial?
How do you approach the decision of when to perform left heart catheterization in a patient with an NSTEMI who recently had an acute ischemic stroke?
What is your stepwise approach to managing no re-flow during PCI?
Do you recommend stepwise de-escalation of dual antiplatelet therapy for patients at high risk of bleeding who have undergone drug-coated balloon angioplasty?
What are your top takeaways from the updated ACS guidelines that will inform changes in clinical practice?
Would acute-onset thrombocytopenia and concern for active bleeding with platelet count below 50,000 prompt you to hold plavix and/or aspirin following PCI that was done 1-2 weeks ago?
For patients presenting with suspected type 1 NSTEMI and atrial fibrillation on anticoagulation, do you favor triple therapy or SAPT with systemic anticoagulation instead while awaiting LHC?